Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukins Inhibitors, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Product Type (Biologics and Non-Biologics), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100600

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 9.9% from 2024-2032
Unit	Value (USD Billion)
Segmentation	By Drug Class TNF Inhibitors Interleukins Inhibitors Others
	By Type Plaque Psoriasis Psoriatic Arthritis Others
	By Product Type Biologics Non-Biologics
	By Route of Administration Oral Parenteral/Systemic Topical
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
	By Region North America (By Drug Class, Type, Product Type, Route of Administration, Distribution Channel, and Country) U.S. (By Type) Canada (By Type) Europe (By Drug Class, Type, Product Type, Route of Administration, Distribution Channel, and Country/Sub-region) U.K. (By Type) Germany (By Type) France (By Type) Italy (By Type) Spain (By Type) Scandinavia (By Type) Rest of Europe (By Type) Asia Pacific (By Drug Class, Type, Product Type, Route of Administration, Distribution Channel, and Country/Sub-region) Japan (By Type) China (By Type) India (By Type) Australia & New Zealand (By Type) Rest of Asia Pacific (By Type) Latin America (By Drug Class, Type, Product Type, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil (By Type) Mexico (By Type) Rest of Latin America (By Type) Middle East & Africa (By Drug Class, Type, Product Type, Route of Administration, Distribution Channel, and Country/Sub-region) GCC (By Type) South Africa (By Type) Rest of the Middle East & Africa (By Type)